Silva Felipe Rodrigues Nogueira, Pereira Amanda Dambrós, Baptista Débora Parra, Pereira Mararlene Ulberg, Spisso Bernardete Ferraz, Gigante Mirna Lúcia, de Campos Braga Patrícia Aparecida, Reyes Félix Guilhermo Reyes, Arisseto-Bragotto Adriana Pavesi
School of Food Engineering, University of Campinas - UNICAMP, Campinas, SP, Brazil.
School of Food Engineering, University of Campinas - UNICAMP, Campinas, SP, Brazil.
Food Res Int. 2020 Nov;137:109440. doi: 10.1016/j.foodres.2020.109440. Epub 2020 Jun 15.
Considering the widespread use of the antibiotic monensin (MON) in the Brazilian livestock and the possibility of residues in milk, this paper aimed to study the stability and fate of this drug during the production of Brazilian Minas Frescal cheese, its effects on milk fermentation and on the physicochemical characteristics of this product. For that, samples of raw milk were fortified with MON at three different nominal concentrations (1.0, 2.0 and 8.0 μg/kg), passed through heat treatment and used to produce Minas Frescal cheese. Pasteurization efficiency was certified by alkaline phosphatase and peroxidase enzyme tests and cheese samples were evaluated for pH, moisture and total protein and fat content. MON residues were determined by LC-MS/MS in the following steps: raw milk, heat-treated milk, whey and cheese. No significant degradation of MON due to heat treatment was observed, suggesting that the drug is resistant to high temperatures. Moreover, the residue levels quantified in cheese and whey demonstrated a concentration of this antibiotic in the curd by about 5-fold, with a small amount of MON being lost during draining. There were no significant differences (p > 0.05) considering the physicochemical parameters evaluated in cheese samples. Fermentation was also not affected by the presence of the drug. The results showed that residues of MON in milk are stable during cheese production and may be concentrated in the final product, as well as indicate the need to establish a MON safe residue level for this food commodity.
鉴于抗生素莫能菌素(MON)在巴西畜牧业中的广泛使用以及牛奶中存在残留的可能性,本文旨在研究该药物在巴西米纳斯弗雷斯科奶酪生产过程中的稳定性和去向,及其对牛奶发酵和该产品理化特性的影响。为此,将原奶样品用三种不同标称浓度(1.0、2.0和8.0μg/kg)的MON进行强化,经过热处理后用于生产米纳斯弗雷斯科奶酪。通过碱性磷酸酶和过氧化物酶测试验证巴氏杀菌效率,并对奶酪样品的pH值、水分以及总蛋白和脂肪含量进行评估。通过液相色谱-串联质谱法(LC-MS/MS)在以下步骤中测定MON残留量:原奶、热处理后的牛奶、乳清和奶酪。未观察到MON因热处理而发生显著降解,这表明该药物耐高温。此外,奶酪和乳清中定量的残留水平表明,凝乳中这种抗生素的浓度约为5倍,在沥干过程中有少量MON损失。考虑到奶酪样品中评估的理化参数,没有显著差异(p>0.05)。发酵也不受药物存在的影响。结果表明,牛奶中的MON残留在奶酪生产过程中是稳定的,并且可能会在最终产品中浓缩,同时也表明需要为这种食品确定MON的安全残留水平。